Merck : MRK

All Merck Articles

1084 Articles

Jon C. Ogg | Feb 1, 2012 at 3:43 PM EST

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Earnings season is still upon us. There are going to be many big earnings reports Thursday and we would consider…

Jon C. Ogg | Jan 31, 2012 at 7:17 AM EST

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s…

Jon C. Ogg | Jan 23, 2012 at 6:33 PM EST

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Jim Cramer has touted several DJIA upside calls in 2012, but on Monday’s MAD MONEY on CNBC Cramer touted Merck…

Paul Ausick | Jan 11, 2012 at 1:37 PM EST

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…

Jon C. Ogg | Jan 10, 2012 at 3:47 PM EST

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) has been on fire due to the rapid interest of hepatitis C treatments and the bidding of…

Paul Ausick | Jan 9, 2012 at 4:07 PM EST

24/7 Wall St. Closing Bell (COST, XOM, AKAM, P, SCCO, MRK, AYI, CBST, AA, INHX, PSOF, IDIX, NFLX, THRX, LTRX)

US markets opened up slightly this morning and have maintained a slight positive tone for most of the day. Today…

Jon C. Ogg | Jan 9, 2012 at 8:09 AM EST

Top Analyst Upgrades & Downgrades (AKAM, GAS, AAPL, ARMH, B, COST, XOM, FR, HTH, IART, IGT, MRK, P, PENN, PVH, RBS, SCCO, THOR)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Jon C. Ogg | Jan 4, 2012 at 8:01 AM EST

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…

Jon C. Ogg | Jan 3, 2012 at 6:40 AM EST

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

As each new year replaces the prior year, 24/7 Wall St. looks at the individual targets on all 30 Dow…

Jon C. Ogg | Dec 29, 2011 at 1:02 PM EST

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones…

Jon C. Ogg | Dec 8, 2011 at 11:14 AM EST

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks…

Jon C. Ogg | Dec 6, 2011 at 12:45 PM EST

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

AuthorDendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment. Unfortunately, PROVENGE sales…

Jon C. Ogg | Dec 2, 2011 at 6:31 AM EST

More DJIA Stocks Set to Hike Dividends Very Soon (DIS, DIA, T, VZ, CSCO, KO, IBM, JNJ, JPM, MMM, PFE, MRK, WMT, DVY, VIG, PFM, HDV)

Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company…

Douglas A. McIntyre | Nov 23, 2011 at 5:53 AM EST

Media Digest (11/23/2011) Reuters, WSJ, FT, Bloomberg

China’s factory activity reaches a 32-month low. (Reuters) Merck (NYSE: MRK) pays $950 million to settle Vioxx charges brought by…

Douglas A. McIntyre | Nov 22, 2011 at 3:58 PM EST

Merck (MRK) Pays $950 Million To Settle Vioxx Cases

Merck (NYSE: MRK) will pay $950 million to settle criminal and civil charges that it inappropriately promoted use of Vioxx, according…

1 … 58 59 60 61 62 … 73

Merck : MRK

All Merck Articles

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

24/7 Wall St. Closing Bell (COST, XOM, AKAM, P, SCCO, MRK, AYI, CBST, AA, INHX, PSOF, IDIX, NFLX, THRX, LTRX)

Top Analyst Upgrades & Downgrades (AKAM, GAS, AAPL, ARMH, B, COST, XOM, FR, HTH, IART, IGT, MRK, P, PENN, PVH, RBS, SCCO, THOR)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

More DJIA Stocks Set to Hike Dividends Very Soon (DIS, DIA, T, VZ, CSCO, KO, IBM, JNJ, JPM, MMM, PFE, MRK, WMT, DVY, VIG, PFM, HDV)

Media Digest (11/23/2011) Reuters, WSJ, FT, Bloomberg

Merck (MRK) Pays $950 Million To Settle Vioxx Cases

“They’re Going to Accuse You of Having Stolen From Your Parents”: George Kamel to Caller Hiding a $50,000 CD From Her Siblings

SLV vs. SIVR: Same Silver, Lower Fee, So Which Physical Silver ETF Should You Actually Hold?

SIL vs. SILJ: Silver Miners and Senior Stability or Junior Leverage After the $120 Break and $60 Consolidation Test?

"They're Going to Accuse You of Having Stolen From Your Parents": George Kamel to Caller Hiding a $50,000 CD From Her Siblings

$400 a Month Starting at 30 Beats $900 a Month Starting at 45. Most People Wait.

“They’re Going to Accuse You of Having Stolen From Your Parents”: George Kamel to Caller Hiding a $50,000 CD From Her Siblings

$400 a Month Starting at 30 Beats $900 a Month Starting at 45. Most People Wait.

Merck : MRK

All Merck Articles

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

24/7 Wall St. Closing Bell (COST, XOM, AKAM, P, SCCO, MRK, AYI, CBST, AA, INHX, PSOF, IDIX, NFLX, THRX, LTRX)

Top Analyst Upgrades & Downgrades (AKAM, GAS, AAPL, ARMH, B, COST, XOM, FR, HTH, IART, IGT, MRK, P, PENN, PVH, RBS, SCCO, THOR)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

DJIA 2012: Best Targets Imply DJIA 13,678 (BAC, JPM, VZ, IBM, CVX, MCD, CSCO, XOM, GE, HPQ, INTC, MRK, PFE, PG, WMT, DIA)

Which Dogs of the Dow Are Best in 2012? (T, VZ, MRK, PFE, GE, DD, JNJ, INTC, PG, MSFT, CVX, JPM, KFT, MCD)

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

More DJIA Stocks Set to Hike Dividends Very Soon (DIS, DIA, T, VZ, CSCO, KO, IBM, JNJ, JPM, MMM, PFE, MRK, WMT, DVY, VIG, PFM, HDV)

Media Digest (11/23/2011) Reuters, WSJ, FT, Bloomberg

Merck (MRK) Pays $950 Million To Settle Vioxx Cases

“They’re Going to Accuse You of Having Stolen From Your Parents”: George Kamel to Caller Hiding a $50,000 CD From Her Siblings

SLV vs. SIVR: Same Silver, Lower Fee, So Which Physical Silver ETF Should You Actually Hold?

SIL vs. SILJ: Silver Miners and Senior Stability or Junior Leverage After the $120 Break and $60 Consolidation Test?

Featured Reads

"They're Going to Accuse You of Having Stolen From Your Parents": George Kamel to Caller Hiding a $50,000 CD From Her Siblings

$400 a Month Starting at 30 Beats $900 a Month Starting at 45. Most People Wait.